Therapeutic effects of direct renin inhibitor in end stage kidney disease patients with maintenance hemodialysis
Not Applicable
- Conditions
- Hypertension,End stage kidney disease
- Registration Number
- JPRN-UMIN000003551
- Lead Sponsor
- Yamamoto general hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 40
Inclusion Criteria
Not provided
Exclusion Criteria
end stage kidney disease patients with maintenance hemodialysis take ACE inhibitore by mouth. The assay of HANP are more than 200 and cardiothorakic ratio more than 55%. Inappropriate condition for the patient. Patients,who refuse informed consent.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Predialysis blood pressure
- Secondary Outcome Measures
Name Time Method